Received Mar 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 52z52 | IM / LA |
Patient experienced no side effects but was given the Arexvy vaccine twice. The patient had already gotten the vaccine in November 2023 which is not in accordance with current vaccine guidelines.
NKA